Maybe we should reconsider such patents says my (Ghent) colleague Sigrid Sterckx in The Telegraph (UK):
The company never pursued the concepts discussed in the patent beyond our Family Traits Inheritance Calculator, nor do we have any plans to do so." But ethicists nonetheless attacked the proposed use of the technology, as well as the decision by the US Patent and Trademark Office to approve it.
Writing in the Genetics in Medicine journal four scientists led by Dr Sigrid Sterckx of the Bioethics Institute in Ghent, Belgium, said: "It is clear that selecting children in ways such as those patented by 23andMe is hugely ethically controversial."
Recent Comments